Catalent, Inc.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Techno…
Drug Manufacturers - Specialty & Generic
US, Somerset [HQ]
Cash Flow Statements
14 Sheets · Starting from NoneIn Million USD. Margins, Growth Rates In %
| Metric | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | None | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Cash Flow (OCF) | 99.00 | 87.00 | 137.00 | 178.00 | 171.00 | 155.00 | 299.00 | 374.00 | 247.00 | 440.00 | 433.00 | 439.00 | 261.00 | - - | |
| Operating Cash (Net) | 99.00 | 87.00 | 137.00 | 178.00 | 171.00 | 155.00 | 299.00 | 374.00 | 247.00 | 440.00 | 433.00 | 439.00 | 261.00 | - - | |
| Accounts Receivable | -18.00 | -64.00 | -23.00 | -38.00 | -7.00 | -54.00 | -54.00 | -33.00 | -118.00 | -150.00 | -186.00 | -73.00 | 53.00 | - - | |
| Accounts Payable | -3.00 | 7.00 | 17.00 | -7.00 | -11.00 | 21.00 | 9.00 | 32.00 | 36.00 | 72.00 | 50.00 | 37.00 | -21.00 | - - | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | -21.00 | -54.00 | -25.00 | 12.00 | -88.00 | -101.00 | -11.00 | 8.00 | -160.00 | -121.00 | -432.00 | -612.00 | -160.00 | - - | |
| Other WC | 2.00 | 1.00 | -9.00 | 67.00 | -49.00 | -33.00 | 46.00 | 11.00 | -43.00 | 33.00 | -36.00 | -448.00 | 160.00 | - - | |
| Investing Activities | |||||||||||||||
| Used Cash (Net) | -50.00 | -494.00 | -122.00 | -171.00 | -271.00 | -137.00 | -309.00 | -919.00 | -1,510.00 | -827.00 | -649.00 | -1,884.00 | -962.00 | - - | |
| Capital Expenditure | -87.00 | -104.00 | -122.00 | -122.00 | -141.00 | -139.00 | -139.00 | -176.00 | -218.00 | -465.00 | -686.00 | -660.00 | -583.00 | - - | |
| Purchases of Investments | - - | - - | - - | - - | - - | - - | - - | - - | -1.00 | -2.00 | -103.00 | -22.00 | -2.00 | - - | |
| Sale/Maturity of Investment | - - | - - | - - | - - | - - | - - | - - | - - | - - | 447.00 | 430.00 | 665.00 | 89.00 | - - | |
| Property, Plant, Equipment (P&PE) | -87.00 | -104.00 | -122.00 | -122.00 | -141.00 | -139.00 | -139.00 | -176.00 | -218.00 | -465.00 | -686.00 | -660.00 | -583.00 | - - | |
| Acquisitions (Net) | - - | -457.00 | -2.00 | -53.00 | -130.00 | -3.00 | -169.00 | -744.00 | -1,291.00 | -358.00 | 140.00 | -1,202.00 | -474.00 | - - | |
| Other Investing Activities | 36.00 | 67.00 | 2.00 | 4.00 | -271.00 | 1.00 | - - | 1.00 | - - | -447.00 | -430.00 | -665.00 | 8.00 | - - | |
| Financing Activities | |||||||||||||||
| Used Cash (Net) | -26.00 | -352.00 | -49.00 | -42.00 | -196.00 | -30.00 | -161.00 | -669.00 | -1,201.00 | -1,001.00 | -142.00 | -1,031.00 | -521.00 | - - | |
| Debt Repayment | -24.00 | -37.00 | -708.00 | -1,758.00 | -879.00 | -18.00 | -224.00 | -22.00 | -1,298.00 | -860.00 | -67.00 | -78.00 | -230.00 | - - | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | -36.00 | -22.00 | -4.00 | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | 959 | 8 | 5 | 291 | 460 | 137 | -120 | 372 | - - | - - | |
| Issued | 3.00 | 1.00 | 1.00 | - - | 948.00 | - - | - - | 277.00 | 445.00 | 1,046.00 | 82.00 | 362.00 | 4.00 | - - | |
| Repurchased | - - | - - | - - | - - | -10.00 | -8.00 | -5.00 | -13.00 | -15.00 | 909.00 | 202.00 | -10.00 | - - | - - | |
| Other Financing Activities | -5.00 | 388.00 | 658.00 | 1,716.00 | 288.00 | -12.00 | 385.00 | 413.00 | 2,084.00 | -56.00 | -53.00 | 761.00 | 747.00 | - - | |
| Cash Balances | |||||||||||||||
| Begin of Period | 164.00 | 205.00 | 139.00 | 106.00 | 74.00 | 151.00 | 131.00 | 288.00 | 410.00 | 345.00 | 953.00 | 896.00 | 449.00 | - - | |
| End of Period | 205.00 | 139.00 | 106.00 | 74.00 | 151.00 | 131.00 | 288.00 | 410.00 | 345.00 | 953.00 | 896.00 | 449.00 | 280.00 | - - | |
| Change | 41.00 | -66.00 | -32.00 | -32.00 | 76.00 | -19.00 | 156.00 | 121.00 | -64.00 | 607.00 | -57.00 | -447.00 | -169.00 | - - | |
| Non-Cash Balances | |||||||||||||||
| Depreciation and Amortization | 115.00 | 129.00 | 152.00 | 142.00 | 140.00 | 140.00 | 146.00 | 190.00 | 228.00 | 253.00 | 289.00 | 378.00 | 422.00 | - - | |
| Stock Based Compensation | 3.00 | 3.00 | 2.00 | 4.00 | 9.00 | 10.00 | 20.00 | - - | 33.00 | 48.00 | 51.00 | 54.00 | 35.00 | - - | |
| Other | 24.00 | 9.00 | 50.00 | 15.00 | 20.00 | 9.00 | 35.00 | 29.00 | 23.00 | 36.00 | -124.00 | 86.00 | 347.00 | - - | |
| Highlighted metrics | |||||||||||||||
| Free Cash Flow (FCF) | 12.00 | -16.00 | 15.00 | 55.00 | 30.00 | 15.00 | 159.00 | 198.00 | 29.00 | -25.00 | -253.00 | -221.00 | -322.00 | - - | |
| Cash Conversion Cycle (CCC) | - - | 71.00 | 68.00 | 76.00 | 75.00 | 85.00 | 91.00 | 85.00 | 104.00 | 99.00 | 116.00 | 111.00 | 121.00 | - - | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
|||||||||||||||
| Forex Effect on Cash | 17.00 | -12.00 | 1.00 | 3.00 | -19.00 | -6.00 | 4.00 | -2.00 | -3.00 | -6.00 | 17.00 | -33.00 | 11.00 | - - |